Back

Acute and short term safety and feasibility of the new OPTIMIZER SMART-system: Is it reasonable to avoid an atrial lead?

18 March 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - CRT Chronic Heart Failure – Treatment EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Axel Kloppe

Marienhospital, Gelsenkirchen (Germany)

18 More presentations in this session

Presentation thumbnail
Doctor D. Schoene (Gelsenkirchen, DE)
Abstract
Presentation thumbnail
Doctor P. Chousou (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Professor A. Quesada Dorador (Valencia, ES)
Abstract Slides
Presentation thumbnail
Mr A. Zweerink (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Professor A. Quesada Dorador (Valencia, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - CRT

The Event

Event poster

EHRA 2018

18 March 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Effect of atrioventricular optimization on cardiac resynchronization response in patients with long interventricular electrical delays: A pooled analysis of the SMART-AV and SMART-CRT trials
9 April 2024
thumbnail
Congress Presentation
Midterm results of the LEADR trial confirm ongoing safety, efficacy, and reliability of the novel, small-diameter OmniaSecure defibrillation lead
31 March 2025
thumbnail
Congress Presentation
Optimization of biventricular cardiac resynchronization improves cardiac power and atrial kinetics in patients with systolic heart failure with often hospitalizations for decompensation
26 August 2022
thumbnail
Congress Presentation
Left atrial appendage occlusion with prior thrombus under OAC: feasibility and safety in a case series of patients with LA dilation and impaired atrial function
14 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources